Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sana Biotechnology Inc has a consensus price target of $12 based on the ratings of 6 analysts. The high is $15 issued by Citigroup on August 9, 2024. The low is $6 issued by Goldman Sachs on November 3, 2022. The 3 most-recent analyst ratings were released by Citigroup, HC Wainwright & Co., and HC Wainwright & Co. on August 9, 2024, August 9, 2024, and May 9, 2024, respectively. With an average price target of $12.67 between Citigroup, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 213.53% upside for Sana Biotechnology Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Sana Biotechnology (NASDAQ:SANA) was reported by Citigroup on August 9, 2024. The analyst firm set a price target for $15.00 expecting SANA to rise to within 12 months (a possible 271.29% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Sana Biotechnology (NASDAQ:SANA) was provided by Citigroup, and Sana Biotechnology maintained their buy rating.
The last upgrade for Sana Biotechnology Inc happened on January 16, 2024 when HC Wainwright & Co. raised their price target to $12. HC Wainwright & Co. previously had a neutral for Sana Biotechnology Inc.
There is no last downgrade for Sana Biotechnology.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sana Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sana Biotechnology was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.
While ratings are subjective and will change, the latest Sana Biotechnology (SANA) rating was a maintained with a price target of $8.00 to $15.00. The current price Sana Biotechnology (SANA) is trading at is $4.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.